Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure

The present study aimed to evaluate whether thymosin α1 (Tα1) increases survival rates through the improvement of immunofunction and inhibition of hepatocyte apoptosis in rats with acute liver failure (ALF). A total of 25 rats were randomly divided into the control group (CG), the model group (MG) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xueliang, Chen, Yunru, Zhang, Jian, Tang, Tiantian, Kong, Ying, Ye, Feng, Zhang, Xi, Liu, Xiaojing, Lin, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840938/
https://www.ncbi.nlm.nih.gov/pubmed/29545840
http://dx.doi.org/10.3892/etm.2018.5843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840938/
https://www.ncbi.nlm.nih.gov/pubmed/29545840
http://dx.doi.org/10.3892/etm.2018.5843

Ejemplares similares